Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)

被引：4

作者：

Yang, Yue ^{[1
]}

Luo, Yi-Dan ^{[1
]}

Zhang, Chen-Bo ^{[1
]}

Xiang, Yang ^{[1
,2
]}

Bai, Xin-Yue ^{[1
]}

Zhang, Die ^{[1
]}

Fu, Zhao-Ying ^{[1
]}

Hao, Ruo-Bing ^{[1
]}

Liu, Xiao-Long ^{[1
]}

机构：

[1] Yanan Univ, Sch Med, Yanan 716000, Peoples R China

[2] Yanan Univ, Coll Phys Educ, Yanan 716000, Peoples R China

来源：

ACS OMEGA | 2024年 / 9卷 / 32期

关键词：

RESPIRATORY SYNDROME-CORONAVIRUS; PAPAIN-LIKE PROTEASE; COVALENT INHIBITORS; WITHANIA-SOMNIFERA; DISCOVERY; DESIGN; AGLYCONE; BAICALIN;

D O I：

10.1021/acsomega.4c03023

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Since 2019, the novel coronavirus (SARS-CoV-2) has caused significant morbidity and millions of deaths worldwide. The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 and its variants, has further highlighted the urgent need for the development of effective therapeutic agents. Currently, the highly conserved and broad-spectrum nature of main proteases (M-pro) renders them of great importance in the field of inhibitor study. In this study, we categorize inhibitors targeting M-pro into three major groups: mimetic, nonmimetic, and natural inhibitors. We then present the research progress of these inhibitors in detail, including their mechanism of action, antiviral activity, pharmacokinetic properties, animal experiments, and clinical studies. This review aims to provide valuable insights and potential avenues for the development of more effective antiviral drugs against SARS-CoV-2.

引用

页码：34196 / 34219

页数：24

共 50 条

[31] On the origins of SARS-CoV-2 main protease inhibitors
Janin, Yves L.
RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 81 - 118
[32] Peptidomimetic inhibitors of SARS-COV-2 main protease
Angeles Bonache, Ma.
Algar, Sergio
Medina, Jessy
Diaz-Agustin, Aitor
Bueno, Paula
Castro, Victoria
Fabrega, Montserrat
Coll, Miquel
Garaigorta, Urtzi
Gastaminza, Pablo
Martin Martinez, Mercedes
Gonzalez-Muniz, Rosario
JOURNAL OF PEPTIDE SCIENCE, 2024, 30
[33] Perspectives on SARS-CoV-2 Main Protease Inhibitors
Gao, Kaifu
Wang, Rui
Chen, Jiahui
Tepe, Jetze J.
Huang, Faqing
Wei, Guo-Wei
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 16922 - 16955
[34] Computational analysis of substrate recognition of Sars-Cov-2 Mpro main protease
Tasci, Hilal Sena
Akkus, Ebru
Yildiz, Muslum
Kocak, Abdulkadir
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2023, 107
[35] Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Narayanan, Anoop
Narwal, Manju
Majowicz, Sydney A.
Varricchio, Carmine
Toner, Shay A.
Ballatore, Carlo
Brancale, Andrea
Murakami, Katsuhiko S.
Jose, Joyce
COMMUNICATIONS BIOLOGY, 2022, 5 (01)
[36] Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan
Manju Narwal
Sydney A. Majowicz
Carmine Varricchio
Shay A. Toner
Carlo Ballatore
Andrea Brancale
Katsuhiko S. Murakami
Joyce Jose
Communications Biology, 5
[37] Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 Mpro
Wang, Zhengyuan
Zhao, Yao
Wang, Qingxing
Xing, Yangfei
Feng, Lu
Kong, Juan
Peng, Chao
Zhang, Leike
Yang, Haitao
Lu, Min
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[38] Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 Mpro
Zhengyuan Wang
Yao Zhao
Qingxing Wang
Yangfei Xing
Lu Feng
Juan Kong
Chao Peng
Leike Zhang
Haitao Yang
Min Lu
Signal Transduction and Targeted Therapy, 6
[39] Design and Evaluation of Peptide Inhibitors Targeting the Dimerization of SARS-CoV-2 Main Protease
Yang, Yi
Zhao, Zhiyi
Li, Xiaoying
Chen, Yian
Liu, Lu
Zhang, Shao-Lin
Yang, Aimin
CHEMBIOCHEM, 2025, 26 (01)
[40] Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review
Xiao, Ya-Qi
Long, Jiao
Zhang, Shuang-Shuang
Zhu, Yuan -Yuan
Gu, Shuang-Xi
BIOORGANIC CHEMISTRY, 2024, 147

← 1 2 3 4 5 →